The importance of Ki-67 proliferation index in small cell lung cancer Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020
Prognostic value of apoptotic index in non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 5s Year: 2004
Interobserver variability of tumor proliferation index and the importance of semiautomated method for counting Ki-67 in lung carcinoma Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016
Evaluation by immunohistochemistry of EGF-R expression before and after chemotherapy in non small cell lung cancer Source: Annual Congress 2005 - Chemotherapy and palliative care Year: 2005
The use of radiolabelled somatostatin analogue scintigraphy in the staging of small cell lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 535s Year: 2005
Composite anatomical–clinical–molecular prognostic model in nonsmall cell lung cancer Source: Eur Respir J 2011; 37: 136-142 Year: 2011
Role of Charlson cormobidity index in the advanced non small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 385s Year: 2006
Ki-67 in non-small cell lung cancer Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012
Correlation of diffusion MRI with the Ki-67 index in non-small cell lung cancer Source: International Congress 2016 – Mixed-up imaging of various chest diseases Year: 2016
A modified ILD-GAP index for patients with non-small cell lung cancer and interstitial lung disease Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018
An evaluation of a videobronchoscopy-based autofluorescence system in lung cancer Source: Eur Respir J 2010; 35: 1185-1187 Year: 2010
Detection of primary lung cancer by tumor targeting imaging Source: Eur Respir J 2002; 20: Suppl. 38, 600s Year: 2002
The expression of Ki-67, a marker of proliferative activity, in resected nonsmall cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 478s Year: 2001
Importance of weight loss definition in the prognostic evaluation of nonsmall cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 477s Year: 2001
Assessment of DNA ploidy and proliferating activity changes in neoplasmatic cells according to TNM classification and clinical stages in non-small cell lung cancer (NSCLC) patients during chemotherapy Source: Eur Respir J 2003; 22: Suppl. 45, 225s Year: 2003
The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 78s Year: 2005
Scintigraphy with 99m Tc-depreotide has a high sensitivity in detecting lung cancer Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques Year: 2007
Pathology and immunohistochemistry of lung cancer Source: Eur Respir Mon; 2009: 44: 15–35 Year: 2009
Telomerase vs CD34 and MIB1 in non small cell lung cancer Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008
Correlation of lung surface area to apoptosis and proliferation in human emphysema Source: Eur Respir J 2005; 25: 250-258 Year: 2005